Lansoprazole sulfone N-oxide-d4

• CAT Number: R011109
• CAS Number: 1190009-70-1
• Molecular Formula: C16H10D4F3N3O4S
• Molecular Weight: 405.38
• Purity: ≥95%
• IUPAC Name: 4,5,6,7-tetradeuterio-2-[[3-methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-2-yl]methylsulfonyl]-1H-benzimidazole
• InChI: InChI=1S/C16H14F3N3O4S/c1-10-13(22(23)7-6-14(10)26-9-16(17,18)19)8-27(24,25)15-20-11-4-2-3-5-12(11)21-15/h2-7H,8-9H2,1H3,(H,20,21)/i2D,3D,4D,5D
• InChIKey: RQCPAMTYJRPELQ-QFFDRWTDSA-N
• SMILES: [2H]C1=C(C(=C2C(=C1[2H])NC(=N2)S(=O)(=O)CC3=[N+](C=CC(=C3C)OCC(F)(F)F)[O-])[2H])[2H]

Lansoprazole sulfone N-oxide-d4（Cat No.:R011109）is a deuterated analogue of lansoprazole sulfone, commonly used in pharmacokinetic studies. Lansoprazole is a proton pump inhibitor (PPI) used to reduce stomach acid production, and its sulfone N-oxide form is a metabolite produced in the liver. The deuterium (d4) labeling enables more precise tracking of the compound in metabolic studies, as the heavy isotope does not interfere with the compound’s biological activity. This makes Lansoprazole sulfone N-oxide-d4 valuable in drug metabolism research, particularly in understanding the pharmacodynamics and pharmacokinetics of lansoprazole in clinical settings.